
    
      A single-dose, two-way, bioequivalence study in up to 26 normal, non-smoking, healthy males
      and females will be utilized to evaluate the pharmacokinetics and bioequivalence of
      Lamotrigine chewable dispersible formulations under fasted conditions.
    
  